CATALONIA.HEALTH organizes the first GO International of 2025 with a German destination. In this webinar, you will be able to connect and learn more about the health sector in Germany. 

This session will address essential aspects for companies in the health sector interested in learning more about the sector in Germany, which has one of the most advanced and diversified life sciences and healthcare ecosystems in the world. Predominant subsectors include biotechnology, pharmaceuticals, medical technology, and digital health. 

Currently, the sector is undergoing significant expansion, driven by digitalization and innovation in medical technologies. Investments in research and development are high, as they have strong government support and a solid infrastructure that encourages innovation. Among the opportunities of this ecosystem are international collaboration, the entry of new companies into the market and growth in areas such as personalized medicine and digital health solutions. With a highly skilled workforce and a network of top-notch research institutions, Germany remains a leader in the life sciences sector in Europe.

This session will be conducted by Germany Trade & Invest (GTAI), the foreign trade and inward investment promotion agency of Germany, which are experts in connecting Germany companies with the world and vice versa. Also, we will count on the presence of BioM Biotech Cluster Development GmbH, a non-profit network organization of the biotechnology industry in Munich and Bavaria that fosters a unique ecosystem for innovation, growth, and value creation in medicine and biotechnology. BioM connects relevant partners and supports Bavarian biotech companies at every stage of their development. The Bavarian Biotech Cluster includes over 520 biotech and pharmaceutical companies, focusing on innovative therapeutics, diagnostics, and technologies, particularly for personalized medicine. We will have Neuraxpharm, a European leader in pharmaceuticals for disorders affecting the central nervous system (CNS), including both psychiatric and neurological disorders. In 2016, they started the acquisition of Spanish and German companies specialized in CNS, which has contributed to the growth and expansion of Neuraxpharm in Europe. 

Finally, we will have the intervention of ACCIÓ (Catalonia Trade & Investment), which is the business competitiveness agency of the Generalitat de Catalunya and supports the internationalization of Catalan companies. They will speak from the Germany office, which fosters ties between Catalonia and Germany, focusing on key sectors such as health, biotechnology, pharmaceuticals and health innovation, among others.

Speakers:  

• Gabriel Flemming, Deputy Director on Healthcare in GTAI. He supports companies expanding into Germany, focusing on sales, R&D, and manufacturing. His expertise in the German life sciences and healthcare sector began during his tenure as an IP Acquisition Manager for a consultancy managing Deutsche Bank's patent value funds. Gabriel holds a Business Administration degree from the University of Munich Business School (LMU). 
• Ariane Doischer, International Relations and Strategic Management, BioM. She focuses on fostering international networks and collaborations, supporting regional SMEs in their biotech internationalization efforts. She organizes Bavarian joint booths or delegations at major conferences and fairs, hosts networking events with global partners, and connects the Bavarian biotech cluster with key global players. With a background in international economics and business, Ariane has extensive healthcare sector experience, advising medical technology companies on international market entry, collaborating on publicly funded projects, and working for one of Germany's largest private hospital groups. 
• Miguel Barrero, Head of Business Development & Innovation, Neuraxpharm. He joined Neuraxpharm in 2015 where he created and developed the corporate departments of Business Development & Licensing, Alliance Management and, recently, Pipeline. Miguel also leads the Intellectual Property department. He has more than 22 years of experience in the pharmaceutical industry in various roles and companies and holds a bachelor's degree in pharmacy from the University of Barcelona and an MBA from the global education institute ESADE.
• Robert Schmidt, Senior Consultant, specialized in the health sector from Berlin office, ACCIÓ.

Addressed to: Companies in the healthcare and biotechnology sectors interested in expanding into the Germany healthcare market. 

Language: English 

Registration:  

• Members of CATALONIA.HEALTH: free 

• No members: 25 € (VAT not included) 
  
  

Questions: Laura Iglesias (Business Development Manager) laura.iglesias@catalonia.health 

With the support of